SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat ® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat ® CDx FLT3 ...
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation today announced FALCO biosystems of Kyoto, Japan, a core business company of FALCO HOLDINGS, working in collaboration with Promega microsatellite ...
In February, the FDA approved the marketing of the first test to detect a genetic disorder known as Fragile X Syndrome or FXS. The test is designed for use in adults who may be potential carriers of ...
The technology being developed at the liquid biopsy company Lexent Bio is designed to help cancer patients. Rather than a focus on diagnostics, they are developing tools that they hope will help ...
Illumina, Inc. ILMN launched the TruSight Oncology (“TSO”) Comprehensive (EU)— a single test that evaluates multiple tumor genes and biomarkers to identify the specific molecular profile of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results